Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-08-11
2009-10-20
Kosar, Andrew D (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S018700, C530S317000, C530S331000
Reexamination Certificate
active
07605126
ABSTRACT:
The present invention discloses compounds of formulae I and II, or pharmaceutically acceptable salts, esters, or prodrugs thereof:which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
REFERENCES:
patent: 6323180 (2001-11-01), Linas-Brunet et al.
patent: 7041698 (2006-05-01), Ripka et al.
patent: 2005/0261200 (2005-11-01), Miao et al.
patent: 2007/0054842 (2007-03-01), Blatt et al.
patent: 2007/0093414 (2007-04-01), Carini et al.
patent: 2007/0281884 (2007-12-01), Sun et al.
patent: 2007/0281885 (2007-12-01), Sun et al.
patent: 2008/0125444 (2008-05-01), Sun et al.
patent: 2008/0181868 (2008-07-01), Sun et al.
patent: WO 2006/043145 (2006-04-01), None
H.-K. Han. AAPS Pharmsci. (2000) 2(1), article 6, pp. 1-11.
P. Ettmayer et al. J. Med. Chem. (2004) 47(10), pp. 2393-2404.
B. Testa. Biochem. Pharm. (2004) 68, pp. 2097-2106.
Chen Zhigang
Gai Yonghua
Liu Dong
Moore Joel D.
Niu Deqiang
Elmore Carolyn S.
Elmore Patent Law Group P.C.
Enanta Pharmaceuticals, Inc.
Harlan Edgar W.
Kosar Andrew D
LandOfFree
Acylaminoheteroaryl hepatitis C virus protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acylaminoheteroaryl hepatitis C virus protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylaminoheteroaryl hepatitis C virus protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4096657